Cocaine addicts prone to cocaine-induced psychosis have lower body mass index than cocaine addicts resistant to cocaine-induced psychosis - Implications for the cocaine model of psychosis proneness

Israel Journal of Psychiatry and Related Sciences

Volumn 42, Issue 1, 2005, Pages 45-50

  Rosse, Richard ^a,b   Deutsch, Stephen ^a,b   Chilton, Melissa ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 23844511488     PISSN: 03337308     EISSN: 26172402     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Satel SL, Southwick SM, Gawin GH. Clinical features of cocaine-induced paranoia. Am J Psychiatry 1991;148:495-498.
2. Unnithan SB, Cutting JC. The cocaine experience: Refuting the concept of a model psychosis? Psychopathology 1992;25:71-78
3. Harris D, Batki SL. Stimulant psychosis: Symptom profile and acute clinical course. Am J Addict 2000;9:28-37.
4. Rosse RB, Collins JP Jr, Fay-McCarthy M, Alim TN, Wyatt RJ, Deutsch SI. Phenomenologic comparison of the idiopathic psychosis of schizophrenia and drug-induced cocaine and phencyclidine psychoses: A retrospective study. Clin Neuropharmacol 1994;17:359-569.
5. Satel SL, Edell WS. Cocaine-induced paranoia and psychosis proneness. Am J Psychiatry 1991;148:1708-1711.
6. Kay SR Opler LA Lindenmayer JP. Reliability and validity of the Positive and Negative Syndrome Scale for Schizophrenics. Psychiatry. 1988; 23: 99-110
7. Boutros NN, Gelernter J, Gooding DC, Cubells J, Young A, Krystal JH, Kosten T. Sensory gating and psychosis vulnerability in cocaine-dependent individuals: preliminary data. Biol Psychiatry 2002;51:683-686.
8. Adler LE, Olincy A, Cawthra E, Hoffer M, Nagamoto HT, Amass L, Freedman R. Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism. Neuropsychopharmacology 2001;25:796.
9. Waldo MC, Adler LE, Leonard S, Olincy A, Ross RG, Harris JG, Freedman R: Familial transmission of risk factors in the first-degree relatives of schizophrenic people. Biol Psychiatry 2001;47:231-239.
10. Cochrane C, Malcolm R, Brewerton T. The role of weight control as a motivation for cocaine abuse. Addict Behav 1998 ;23:201-207.
11. Louis ED, Marder K, Jurewicz EC, Watner D, Levy G, Mejia-Santana H. Body mass index in essential tremor. Arch Neurol 2002 ;59:1273-1277
12. Czobor P, Volavka J, Sheitman B, Lindenmayer JP, Citrome L, McEvoy J, Cooper TB, Chakos M, Lieberman JA. Antipsychotic-induced weight gain and therapeutic response: A differential association. J Clin Psychopharmacol 2002;22:244-251.
13. Singh MM, DeDios LV, Kline NS. Weight as a correlate of clinical response to psychotropic drugs. Psychosomatics 1970;9:562-570.
14. Baptista T. Body weight gain induced by antipsychotic drugs: mechanisms and management. Acta Psychiatr Scand 1999;100:3-16.
15. Taylor DM, McAskill R. Atypical antipsychotics and weight gain - a systematic review. Acta Psychiatr Scan 2000;101:416-432.
16. Spitzer, R L, Williams J BW, Gibbon M, First M B, Structured Clinical Interview for DSM-III-R, Patient Edition (SCID-P), Washington, D.C.: American Psychiatrie, 1990.
17. Lee YW, Hennig B, Fiala M, Kim KS, Toborek M. Cocaine activates redox-regulated transcription factors and induces TNF-alpha expression in human brain endothelial cells. Brain Res 2001;920:125-133.
18. Rossi Fanelli F, Laviano A. Cancer anorexia: A model for the understanding and treatment of secondary anorexia. Int J Cardiol 2002;85:67-72.
19. Wassink TH, Crowe RR, Andreasen NC. Tumor necrosis factor receptor-II: Heritability and effect on brain morphology in schizophrenia. Mol Psychiatry 2000;5:678-682.
20. Jun TY, Pae CU, Chae JH, Bahk WM, Kim KS, Han H, Serretti A. TNFB polymorphism may be associated with schizophrenia in the Korean population. Schizophr Res. 2003;61:39-45.
21. Argilés J M, López-Soriano J, Busquets S, López-Soriano F J. Journey from cachexia to obesity by TNF. FASEB J 1997;11:743-751.
22. Basile VS, Masellis M, McIntyre RS, Meltzer HY, Lieberman JA, Kennedy JL. Genetic dissection of atypical antipsychotic-induced weight gain: Novel preliminary data on the pharmacogenetic puzzle. J Clin Psychiatry 2001;62:45-66
23. Regnier CH, Tomasetto C, Moog-Lutz C, Chenard MP, Wendling C, Basset P, Rio MC. Presence of a new conserved domain in CART1, a novel member of the tumor necrosis factor receptor-associated protein family, which is expressed in breast carcinoma. J Biol Chem 1995;270:25715-25721.
24. Kask A, Schioth HB, Mutulis F, Wikberg JES, Rago L. Anorexigenic cocaine- and amphetamine-regulated transcript peptide intensifies fear reactions in rats. Brain Res 2000;857:283-285.
25. Asakawa A, Inui A, Yuzuriha H, Nagata T, Kaga T, Ueno N, Fujino MA, Kasuga M. Cocaine-amphetamine-regulated transcript influences energy metabolism, anxiety and gastric emptying in mice. Horm Metab Res.2001;33:554-558.
26. Bannon AW, Seda J, Carmouche M, Francis JM, Jarosinski MA, Douglass J. Multiple behavioral effects of cocaine- and amphetamine-regulated transcript (CART) peptides in mice: CART 42-89 and CART 49-89 differ in potency and activity. J Pharmacol Exp Ther 2001;299:1021-1026.
27. Jo YH, Talmage DA, Role LW Nicotinic receptor-mediated effects on appetite and food intake. J Neurobiol 2002;53:618-632
28. Freedman R, Hall M, Adler LE, et al. Evidence in post-mortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biol Psychiatry 1995;38:22-33.
29. Wahlestedt C, Karoum F, Jaskiw G, Wyatt RJ, Larhammer D, Ekman R, Reis DJ. Cocaine-induced reduction of brain neuropeptide Y synthesis dependent on medial prefrontal cortex. Proc Natl Acad Sci USA 1991;88:2078-2082.
30. Westwood SC, Hanson GR. Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems. J Pharmacol Exp Ther 1999;288:1160-1166.
31. Baptista T, Beaulieu S. Are leptin and cytokines involved in body weight gain during treatment with antipsychotic drugs? Can J Psychiatry 2002;47:742-749.